[The significance of HIV to bone mineral density]. 2017

Maria Wessman, and Nina Weis, and Terese L Katzenstein, and Anne-Mette Lebech, and Kristina Thorsteinsson, and Ann-Brit Eg Hansen, and Jens-Erik Beck Jensen
maria.krystyna.jakowlew.wessman@regionh.dk.

The life expectancy in well-treated HIV-infected persons approaches that of the general population, but HIV-infected persons have a greater incidence of fractures and osteoporosis. A decrease in bone mineral density is observed primarily during the first 1-2 years of antiretroviral therapy. Dual X-ray absorptiometry scan should be considered in HIV-infected men ≥ 50 years and postmenopausal women. In case of osteoporosis, bisphosphonate treatment should follow guidelines for the general population. Future research should focus on pathogenesis and prevention of bone density loss in HIV.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010024 Osteoporosis Reduction of bone mass without alteration in the composition of bone, leading to fractures. Primary osteoporosis can be of two major types: postmenopausal osteoporosis (OSTEOPOROSIS, POSTMENOPAUSAL) and age-related or senile osteoporosis. Age-Related Osteoporosis,Bone Loss, Age-Related,Osteoporosis, Age-Related,Osteoporosis, Post-Traumatic,Osteoporosis, Senile,Senile Osteoporosis,Osteoporosis, Involutional,Age Related Osteoporosis,Age-Related Bone Loss,Age-Related Bone Losses,Age-Related Osteoporoses,Bone Loss, Age Related,Bone Losses, Age-Related,Osteoporoses,Osteoporoses, Age-Related,Osteoporoses, Senile,Osteoporosis, Age Related,Osteoporosis, Post Traumatic,Post-Traumatic Osteoporoses,Post-Traumatic Osteoporosis,Senile Osteoporoses
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D015502 Absorptiometry, Photon A noninvasive method for assessing BODY COMPOSITION. It is based on the differential absorption of X-RAYS (or GAMMA RAYS) by different tissues such as bone, fat and other soft tissues. The source of (X-ray or gamma-ray) photon beam is generated either from radioisotopes such as GADOLINIUM 153, IODINE 125, or Americanium 241 which emit GAMMA RAYS in the appropriate range; or from an X-ray tube which produces X-RAYS in the desired range. It is primarily used for quantitating BONE MINERAL CONTENT, especially for the diagnosis of OSTEOPOROSIS, and also in measuring BONE MINERALIZATION. Absorptiometry, X-Ray,Dual-Photon Absorptiometry,Photodensitometry, X-Ray,Photon Absorptiometry,Single-Photon Absorptiometry,X-Ray Absorptiometry,Absorptiometry, Dual X-Ray,Absorptiometry, Dual-Energy Radiographic,Absorptiometry, Dual-Energy X-Ray,DEXA Scan,DPX Absorptiometry,DXA Scan,Densitometry, X-Ray,Densitometry, Xray,Dual X-Ray Absorptiometry,Dual-Energy Radiographic Absorptiometry,Dual-Energy X-Ray Absorptiometry,Dual-Energy X-Ray Absorptiometry Scan,Radiographic Absorptiometry, Dual-Energy,X-Ray Absorptiometry, Dual-Energy,X-Ray Photodensitometry,Absorptiometries, DPX,Absorptiometry, DPX,Absorptiometry, Dual Energy Radiographic,Absorptiometry, Dual Energy X Ray,Absorptiometry, Dual X Ray,Absorptiometry, Dual-Photon,Absorptiometry, Single-Photon,Absorptiometry, X Ray,DEXA Scans,DXA Scans,Densitometry, X Ray,Dual Energy Radiographic Absorptiometry,Dual Energy X Ray Absorptiometry,Dual Energy X Ray Absorptiometry Scan,Dual Photon Absorptiometry,Dual X Ray Absorptiometry,Photodensitometry, X Ray,Radiographic Absorptiometry, Dual Energy,Scan, DEXA,Scan, DXA,Scans, DEXA,Scans, DXA,Single Photon Absorptiometry,X Ray Absorptiometry,X Ray Absorptiometry, Dual Energy,X Ray Photodensitometry,X-Ray Absorptiometry, Dual,X-Ray Densitometry,Xray Densitometry
D015519 Bone Density The amount of mineral per square centimeter of BONE. This is the definition used in clinical practice. Actual bone density would be expressed in grams per milliliter. It is most frequently measured by X-RAY ABSORPTIOMETRY or TOMOGRAPHY, X RAY COMPUTED. Bone density is an important predictor for OSTEOPOROSIS. Bone Mineral Content,Bone Mineral Density,Bone Densities,Bone Mineral Contents,Bone Mineral Densities,Density, Bone,Density, Bone Mineral
D015658 HIV Infections Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS). HTLV-III Infections,HTLV-III-LAV Infections,T-Lymphotropic Virus Type III Infections, Human,HIV Coinfection,Coinfection, HIV,Coinfections, HIV,HIV Coinfections,HIV Infection,HTLV III Infections,HTLV III LAV Infections,HTLV-III Infection,HTLV-III-LAV Infection,Infection, HIV,Infection, HTLV-III,Infection, HTLV-III-LAV,Infections, HIV,Infections, HTLV-III,Infections, HTLV-III-LAV,T Lymphotropic Virus Type III Infections, Human
D017410 Practice Guidelines as Topic Works about directions or principles presenting current or future rules of policy for assisting health care practitioners in patient care decisions regarding diagnosis, therapy, or related clinical circumstances. The guidelines may be developed by government agencies at any level, institutions, professional societies, governing boards, or by the convening of expert panels. The guidelines form a basis for the evaluation of all aspects of health care and delivery. Clinical Guidelines as Topic,Best Practices,Best Practice

Related Publications

Maria Wessman, and Nina Weis, and Terese L Katzenstein, and Anne-Mette Lebech, and Kristina Thorsteinsson, and Ann-Brit Eg Hansen, and Jens-Erik Beck Jensen
February 2010, Current opinion in infectious diseases,
Maria Wessman, and Nina Weis, and Terese L Katzenstein, and Anne-Mette Lebech, and Kristina Thorsteinsson, and Ann-Brit Eg Hansen, and Jens-Erik Beck Jensen
March 2015, Germs,
Maria Wessman, and Nina Weis, and Terese L Katzenstein, and Anne-Mette Lebech, and Kristina Thorsteinsson, and Ann-Brit Eg Hansen, and Jens-Erik Beck Jensen
December 2006, Current opinion in endocrinology & diabetes,
Maria Wessman, and Nina Weis, and Terese L Katzenstein, and Anne-Mette Lebech, and Kristina Thorsteinsson, and Ann-Brit Eg Hansen, and Jens-Erik Beck Jensen
March 1995, Nihon Sanka Fujinka Gakkai zasshi,
Maria Wessman, and Nina Weis, and Terese L Katzenstein, and Anne-Mette Lebech, and Kristina Thorsteinsson, and Ann-Brit Eg Hansen, and Jens-Erik Beck Jensen
March 2007, AIDS (London, England),
Maria Wessman, and Nina Weis, and Terese L Katzenstein, and Anne-Mette Lebech, and Kristina Thorsteinsson, and Ann-Brit Eg Hansen, and Jens-Erik Beck Jensen
September 2001, AIDS (London, England),
Maria Wessman, and Nina Weis, and Terese L Katzenstein, and Anne-Mette Lebech, and Kristina Thorsteinsson, and Ann-Brit Eg Hansen, and Jens-Erik Beck Jensen
January 2016, Expert opinion on pharmacotherapy,
Maria Wessman, and Nina Weis, and Terese L Katzenstein, and Anne-Mette Lebech, and Kristina Thorsteinsson, and Ann-Brit Eg Hansen, and Jens-Erik Beck Jensen
April 2015, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research,
Maria Wessman, and Nina Weis, and Terese L Katzenstein, and Anne-Mette Lebech, and Kristina Thorsteinsson, and Ann-Brit Eg Hansen, and Jens-Erik Beck Jensen
January 2013, AIDS reviews,
Maria Wessman, and Nina Weis, and Terese L Katzenstein, and Anne-Mette Lebech, and Kristina Thorsteinsson, and Ann-Brit Eg Hansen, and Jens-Erik Beck Jensen
May 2002, Journal of acquired immune deficiency syndromes (1999),
Copied contents to your clipboard!